Abstract
The accurate prediction of the in vivo pharmacokinetics of a new potential drug compound based on only its virtual structure is the ultimate goal of in silico ADME-Tox property modeling. A comprehensive review is made on recent studies concerning the A (absorption) in ADME-Tox, i.e. the in silico modeling of both Caco-2 permeability and human intestinal absorption. The data sets used, the descriptors selected to build the models, the variable selection methods, the modeling techniques and the performed model validation are critically discussed. It was concluded that reliable models which improve the success rate of compound selection and drug development are still lacking. Limiting the quality of the models are, for instance, inappropriate compilation of data sets, lack of an appropriate outlier detection and unrepresentativeness of training and test sets for the data population. The definition of some best practices or guidelines for the different steps of the modeling procedure might improve the predictions and make the procedure uniform, i.e. “standard tools” in drug development would become available.
Keywords: ADME-tox, Caco-2, drug absorption, human intestinal absorption, in silico methods, QSAR, pharmacokinetics, Combinatorial chemistry, Computer-Aided Drug Design, pharmacophore, in vitro
Combinatorial Chemistry & High Throughput Screening
Title: In Silico Predictions of ADME-Tox Properties: Drug Absorption
Volume: 14 Issue: 5
Author(s): Tessy Geerts and Yvan Vander Heyden
Affiliation:
Keywords: ADME-tox, Caco-2, drug absorption, human intestinal absorption, in silico methods, QSAR, pharmacokinetics, Combinatorial chemistry, Computer-Aided Drug Design, pharmacophore, in vitro
Abstract: The accurate prediction of the in vivo pharmacokinetics of a new potential drug compound based on only its virtual structure is the ultimate goal of in silico ADME-Tox property modeling. A comprehensive review is made on recent studies concerning the A (absorption) in ADME-Tox, i.e. the in silico modeling of both Caco-2 permeability and human intestinal absorption. The data sets used, the descriptors selected to build the models, the variable selection methods, the modeling techniques and the performed model validation are critically discussed. It was concluded that reliable models which improve the success rate of compound selection and drug development are still lacking. Limiting the quality of the models are, for instance, inappropriate compilation of data sets, lack of an appropriate outlier detection and unrepresentativeness of training and test sets for the data population. The definition of some best practices or guidelines for the different steps of the modeling procedure might improve the predictions and make the procedure uniform, i.e. “standard tools” in drug development would become available.
Export Options
About this article
Cite this article as:
Geerts Tessy and Vander Heyden Yvan, In Silico Predictions of ADME-Tox Properties: Drug Absorption, Combinatorial Chemistry & High Throughput Screening 2011; 14 (5) . https://dx.doi.org/10.2174/138620711795508359
DOI https://dx.doi.org/10.2174/138620711795508359 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pre-Clinical Considerations in the Assessment of Immunogenicity for Protein Therapeutics
Current Drug Safety Complications Following Stem Cell Therapy in Inflammatory Bowel Disease
Current Stem Cell Research & Therapy Microarray Data Integration: Frameworks and a List of Underlying Issues
Current Bioinformatics Regulation and Quantification of Cellular Mitochondrial Morphology and Content
Current Pharmaceutical Design Gadolinium Oxide Nanoparticles as Potential Multimodal Imaging and Therapeutic Agents
Current Topics in Medicinal Chemistry Novel Stereoselective Oximes: Their Synthesis and Anti-leishmanials Evaluation
Current Bioactive Compounds Differences of Protein Fractions Among Fresh, Frozen and Powdered Donkey Milk
Recent Patents on Food, Nutrition & Agriculture 6-Mercaptopurine for Azathioprine Intolerant Inflammatory Bowel Disease: Literature Search and Reappraisal of Own Data
Inflammation & Allergy - Drug Targets (Discontinued) Requirements and Perspectives for Integrating Metabolomics with other Omics Data
Current Metabolomics Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients
Current Cancer Drug Targets Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal α2-Adrenoceptors Enhance Cell Proliferation and Mammary Tumor Growth Acting Through both the Stroma and the Tumor Cells
Current Cancer Drug Targets Recent Progress on the Applications of Multifunctional Glyconanoparticles
Current Pharmaceutical Design A3 Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Exosome-like Nanoparticles: A New Type of Nanocarrier
Current Medicinal Chemistry Improving of Nutraceutical Features of Many Important Mediterranean Vegetables by Inoculation with a New Commercial Product
Current Pharmaceutical Biotechnology Biomarkers for Colorectal Cancer: Identification Through Proteomics
Current Proteomics Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Applications of Aptamers in Targeted Imaging: State of the Art
Current Topics in Medicinal Chemistry Moderate Hyperhomocysteinemia and Immune Activation
Current Pharmaceutical Biotechnology